Evidence map›Paper›PMID 40479337›Full record

ReviewPravention und Gesundheitsforderung2022

[Resistance against preventive measures during the COVID-19 pandemic: causes and strategies for minimization].

Matthias R Hastall, Viviane Scherenberg

Abstract readEnglish AbstractReview
In one paragraph

Review in Pravention und Gesundheitsforderung, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Risk, Obligation, and Public Noncompliance with Mobility Directives in China during the COVID-19 Pandemic.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matthias R HastallFakultät Rehabilitationswissenschaften, Fachgebiet Qualitative Forschungsmethoden und strategische Kommunikation für Gesundheit, Inklusion und Teilhabe, Technische Universität Dortmund, Emil-Figge-Str. 50, 44227 Dortmund, Deutschland.ORCID 0000-0003-1766-3567
Viviane ScherenbergFachbereich Public Health und Umweltgesundheit, APOLLON Hochschule der Gesundheitswirtschaft GmbH, Universitätsallee 18, 28359 Bremen, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: During the coronavirus disease 2019 (COVID-19) pandemic, resistance against demonstrably effective preventive measures were frequently observed. Such "reactance," characterized by anger and negative cognitions, is experienced (according to psychological reactance theory) when a threat to subjectively important freedoms or attempts to change attitudes or behaviors is perceived. Objectives: This paper discusses the role of defensive processes in the context of the COVID-19 pandemic from the perspective of an evidence-based and defense-sensitive risk and crisis communication. Triggers and influencing factors of defensive processes are discussed, as well as techniques for minimizing these unwanted reactions. Results: Defensive reactions should always be anticipated, at least to some extent, but can be reduced through a defense-sensitive communication design. This includes a professional presentation, a respectful and stigma-sensitive approach, positive and efficacy-bolstering information, and by avoiding emotionally overwhelming information such as strong negative emotional appeals or strong loss framings. Conclusion: Communicators should be aware that defensive reactions can be triggered as well as minimized through certain features of risk communication. A consistent, clear, and tailored communication approach is needed to reduce uncertainties, defensiveness, and irritation.

Indexed as

Compliance behaviorCoronaHealth communicationPrevention behaviorPsychological reactance

Identifiers

PMID40479337
PMCPMC9208250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.